Dormant breast cancer cells may survive treatment behind cellular barriers
Researchers mapped breast tumors and identified clusters of quiescent cancer cells that can evade chemotherapy and later reactivate. These dormant cells are often surrounded by immune and connective tissue cells that may act as a protective shield. The findings suggest that future therapies may need to target both actively dividing and dormant cancer cells to prevent relapse.
The investigation combined single-cell gene sequencing with spatial mapping to locate inactive cells within untreated tumors. This dual method revealed that these hibernating cells gather in isolated pockets, often bordered by immune and connective tissue that may form a defensive barrier.
Dormancy seems triggered by environmental stress, such as limited blood flow or nutrients. Understanding the cellular surroundings that shelter these quiet populations could enable combination therapies that disrupt this niche, potentially lowering the odds of cancer returning after initial treatment.
This research could shift oncological strategies toward dismantling the protective niches that harbor dormant cells. If validated, future treatments may pair standard chemotherapy with agents designed to awaken or eliminate these hibernating populations. Patients with aggressive breast cancer subtypes could experience fewer recurrences, though translating these findings into clinical practice may take considerable time. Ultimately, this work may lead to more durable remissions and personalized post-treatment monitoring.